Cargando…
A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma
EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791207/ https://www.ncbi.nlm.nih.gov/pubmed/33437790 http://dx.doi.org/10.21037/atm-20-1421 |
_version_ | 1783633561305219072 |
---|---|
author | Sun, Li-Yang Zhu, Hong Diao, Yong-Kang Xing, Hao Liang, Lei Li, Jie Zhou, Ya-Hao Gu, Wei-Min Chen, Ting-Hao Zeng, Yong-Yi Pawlik, Timothy M. Lau, Wan Yee Li, Chao Shen, Feng Zhang, Cheng-Wu Yang, Tian |
author_facet | Sun, Li-Yang Zhu, Hong Diao, Yong-Kang Xing, Hao Liang, Lei Li, Jie Zhou, Ya-Hao Gu, Wei-Min Chen, Ting-Hao Zeng, Yong-Yi Pawlik, Timothy M. Lau, Wan Yee Li, Chao Shen, Feng Zhang, Cheng-Wu Yang, Tian |
author_sort | Sun, Li-Yang |
collection | PubMed |
description | EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice. METHODS: Clinical data of patients who underwent hepatectomy for HCC at 8 hospitals from a multicenter database were retrospectively analyzed. The predictive accuracy of ALBI and APRI relative to 30-day overall and major morbidity were evaluated using area under the receiver operating characteristic curves (AUC). Based on multivariable logistic regression analyses, preoperative and postoperative nomogram models and consequent online calculators were constructed to predict overall and major morbidity, respectively. RESULTS: Among 2,301 patients, 725 (31.5%) experienced postoperative complications (major morbidity, 35.9%, 260/725). Multivariable analyses identified high ALBI grade (>−2.6) and APRI grade (>1.5) as independent risk factors associated with overall and major morbidity in both preoperative and postoperative prediction models. Two nomogram predictive models and corresponding online calculators that combined ALBI and APRI were subsequently constructed. The AUCs of the preoperative and postoperative models were 0.728 and 0.742 to predict overall morbidity, and 0.739 and 0.713 to predict major morbidity, respectively, which were much higher than those of Child-Pugh score and the model for end-stage liver disease (MELD). Using the bootstrap validation method, the resulting models were internally validated well. CONCLUSIONS: Preoperative ALBI and APRI scores can predict postoperative morbidity following hepatectomy for HCC. An easy-to-use online calculator that combined ALBI and APRI was proposed for individually predicting the probabilities of postoperative overall and major morbidity before and immediately after surgery, so as to provide useful information to inform conversations about surgical risks. |
format | Online Article Text |
id | pubmed-7791207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-77912072021-01-11 A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma Sun, Li-Yang Zhu, Hong Diao, Yong-Kang Xing, Hao Liang, Lei Li, Jie Zhou, Ya-Hao Gu, Wei-Min Chen, Ting-Hao Zeng, Yong-Yi Pawlik, Timothy M. Lau, Wan Yee Li, Chao Shen, Feng Zhang, Cheng-Wu Yang, Tian Ann Transl Med Original Article EMAIL: zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com. BACKGROUND: Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice. METHODS: Clinical data of patients who underwent hepatectomy for HCC at 8 hospitals from a multicenter database were retrospectively analyzed. The predictive accuracy of ALBI and APRI relative to 30-day overall and major morbidity were evaluated using area under the receiver operating characteristic curves (AUC). Based on multivariable logistic regression analyses, preoperative and postoperative nomogram models and consequent online calculators were constructed to predict overall and major morbidity, respectively. RESULTS: Among 2,301 patients, 725 (31.5%) experienced postoperative complications (major morbidity, 35.9%, 260/725). Multivariable analyses identified high ALBI grade (>−2.6) and APRI grade (>1.5) as independent risk factors associated with overall and major morbidity in both preoperative and postoperative prediction models. Two nomogram predictive models and corresponding online calculators that combined ALBI and APRI were subsequently constructed. The AUCs of the preoperative and postoperative models were 0.728 and 0.742 to predict overall morbidity, and 0.739 and 0.713 to predict major morbidity, respectively, which were much higher than those of Child-Pugh score and the model for end-stage liver disease (MELD). Using the bootstrap validation method, the resulting models were internally validated well. CONCLUSIONS: Preoperative ALBI and APRI scores can predict postoperative morbidity following hepatectomy for HCC. An easy-to-use online calculator that combined ALBI and APRI was proposed for individually predicting the probabilities of postoperative overall and major morbidity before and immediately after surgery, so as to provide useful information to inform conversations about surgical risks. AME Publishing Company 2020-12 /pmc/articles/PMC7791207/ /pubmed/33437790 http://dx.doi.org/10.21037/atm-20-1421 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Sun, Li-Yang Zhu, Hong Diao, Yong-Kang Xing, Hao Liang, Lei Li, Jie Zhou, Ya-Hao Gu, Wei-Min Chen, Ting-Hao Zeng, Yong-Yi Pawlik, Timothy M. Lau, Wan Yee Li, Chao Shen, Feng Zhang, Cheng-Wu Yang, Tian A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title | A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title_full | A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title_fullStr | A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title_full_unstemmed | A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title_short | A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
title_sort | novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791207/ https://www.ncbi.nlm.nih.gov/pubmed/33437790 http://dx.doi.org/10.21037/atm-20-1421 |
work_keys_str_mv | AT sunliyang anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhuhong anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT diaoyongkang anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT xinghao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lianglei anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lijie anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhouyahao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT guweimin anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT chentinghao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zengyongyi anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT pawliktimothym anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lauwanyee anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lichao anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT shenfeng anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhangchengwu anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT yangtian anovelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT sunliyang novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhuhong novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT diaoyongkang novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT xinghao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lianglei novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lijie novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhouyahao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT guweimin novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT chentinghao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zengyongyi novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT pawliktimothym novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lauwanyee novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT lichao novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT shenfeng novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT zhangchengwu novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma AT yangtian novelonlinecalculatorbasedonalbuminbilirubinandaspartatetransaminasetoplateletratioindexforpredictingpostoperativemorbidityfollowinghepatectomyforhepatocellularcarcinoma |